

Instance: Amlodipin-AB-tabl-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1302"
* subject = Reference(Amlodipin-AB-tabl-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1302-Aurobindo)



Instance: Amlodipin-Sandoz-Impexeco-tabl-deelb-Besilaat-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1307"
* subject = Reference(Amlodipin-Sandoz-Impexeco-tabl-deelb-Besilaat-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1307-Impexeco)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1308"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1308-Sandoz)



Instance: Amlodipine-EG-PIP-tabl-deelb-Besilate-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1303"
* subject = Reference(Amlodipine-EG-PIP-tabl-deelb-Besilate-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1303-PI-Pharma)



Instance: Amlodipine-EG-tabl-deelb-Besilate-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1304"
* subject = Reference(Amlodipine-EG-tabl-deelb-Besilate-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1304-EG)



Instance: Amlodipine-Mylan-tabl-deelb-Besilate-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1305"
* subject = Reference(Amlodipine-Mylan-tabl-deelb-Besilate-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1305-Mylan)



Instance: Amlodipine-Teva-tabl-deelb-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1306"
* subject = Reference(Amlodipine-Teva-tabl-deelb-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1306-Teva)



Instance: Amlor-harde-caps-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1300"
* subject = Reference(Amlor-harde-caps-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1300-Upjohn)



Instance: Amlodipin-AB-tabl-5-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1311"
* subject = Reference(Amlodipin-AB-tabl-5-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1311-Aurobindo)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1316"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1316-Sandoz)



Instance: Amlodipine-EG-tabl-Besilate-5-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1312"
* subject = Reference(Amlodipine-EG-tabl-Besilate-5-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1312-EG)



Instance: Amlodipine-Mylan-tabl-deelb-Besilate-5-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1313"
* subject = Reference(Amlodipine-Mylan-tabl-deelb-Besilate-5-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1313-Mylan)



Instance: Amlodipine-Teva-tabl-deelb-5-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1314"
* subject = Reference(Amlodipine-Teva-tabl-deelb-5-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1314-Teva)



Instance: Amlor-harde-caps-5-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1309"
* subject = Reference(Amlor-harde-caps-5-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1309-Upjohn)



Instance: Amlodipine-Belisate-Mylan-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1447"
* subject = Reference(Amlodipine-Belisate-Mylan-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1447-Mylan-EPD)



Instance: Amlogal-Divule-omh-tabl-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1212"
* subject = Reference(Amlogal-Divule-omh-tabl-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1212-SMB)



Instance: Amlodipine-Krka-tabl-10-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "9200"
* subject = Reference(Amlodipine-Krka-tabl-10-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-9200-Krka)



Instance: Amlodipine-Krka-tabl-5-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "9200"
* subject = Reference(Amlodipine-Krka-tabl-5-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-9200-Krka)



Instance: Tegretol-tabl-geregul-afgifte-deelb-CR-200-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1355"
* subject = Reference(Tegretol-tabl-geregul-afgifte-deelb-CR-200-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1355-Novartis-Pharma)



Instance: Tegretol-tabl-geregul-afgifte-deelb-CR-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1357"
* subject = Reference(Tegretol-tabl-geregul-afgifte-deelb-CR-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1357-Novartis-Pharma)



Instance: Tegretol-siroop-susp-100-mg-5-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1357"
* subject = Reference(Tegretol-siroop-susp-100-mg-5-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1357-Novartis-Pharma)



Instance: Tegretol-tabl-deelb-200-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1356"
* subject = Reference(Tegretol-tabl-deelb-200-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1356-Novartis-Pharma)



Instance: Extrapan-5-transderm-lok-gel-50-mg-1-g-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1437"
* subject = Reference(Extrapan-5-transderm-lok-gel-50-mg-1-g-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1437-Qualiphar)



Instance: Ibuprofen-Kela-5-transderm-lok-gel-50-mg-1-g-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1438"
* subject = Reference(Ibuprofen-Kela-5-transderm-lok-gel-50-mg-1-g-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1438-Kela)



Instance: Ibuprofen-Teva-5-transderm-lok-gel-50-mg-1-g-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1439"
* subject = Reference(Ibuprofen-Teva-5-transderm-lok-gel-50-mg-1-g-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1439-Teva)



Instance: Pedea-inf-oploss-i-v-amp-10-mg-2-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "2519"
* subject = Reference(Pedea-inf-oploss-i-v-amp-10-mg-2-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-2519-Recordati)



Instance: Ibuprofen-B-Braun-inf-oploss-i-v-flac-200-mg-50-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "3534"
* subject = Reference(Ibuprofen-B-Braun-inf-oploss-i-v-flac-200-mg-50-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-3534-B-Braun)



Instance: Ibuprofen-B-Braun-inf-oploss-i-v-flac-400-mg-100-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "3534"
* subject = Reference(Ibuprofen-B-Braun-inf-oploss-i-v-flac-400-mg-100-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-3534-B-Braun)



Instance: Ibuprofen-B-Braun-inf-oploss-i-v-flac-600-mg-100-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "3534"
* subject = Reference(Ibuprofen-B-Braun-inf-oploss-i-v-flac-600-mg-100-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-3534-B-Braun)



Instance: Brufen-tabl-verl-afgifte-Retard-800-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1447"
* subject = Reference(Brufen-tabl-verl-afgifte-Retard-800-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1447-Mylan-EPD)



Instance: Ibuprofen-EG-tabl-verl-afgifte-800-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1448"
* subject = Reference(Ibuprofen-EG-tabl-verl-afgifte-800-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1448-EG)



Instance: Nurofen-zachte-kauwcaps-Kinderen-100-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1417"
* subject = Reference(Nurofen-zachte-kauwcaps-Kinderen-100-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1417-Reckitt-Benckiser)



Instance: Algidrin-siroop-susp-100-mg-5-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1412"
* subject = Reference(Algidrin-siroop-susp-100-mg-5-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1412-I-D-Phar)



Instance: Nurofen-2-siroop-susp-zonder-suiker-Kinderen-100-mg-5-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1414"
* subject = Reference(Nurofen-2-siroop-susp-zonder-suiker-Kinderen-100-mg-5-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1414-Reckitt-Benckiser)



Instance: Nurofen-2-siroop-susp-zonder-suiker-Rood-Kinderen-100-mg-5--RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1415"
* subject = Reference(Nurofen-2-siroop-susp-zonder-suiker-Rood-Kinderen-100-mg-5--MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1415-Reckitt-Benckiser)



Instance: Perdophen-2-siroop-susp-100-mg-5-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1416"
* subject = Reference(Perdophen-2-siroop-susp-100-mg-5-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1416-Johnson-Johnson-Consumer)



Instance: Ibuprofen-EG-omh-tabl-200-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1425"
* subject = Reference(Ibuprofen-EG-omh-tabl-200-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1425-EG)



Instance: Ibuprofen-Sandoz-filmomh-tabl-200-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1426"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-200-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1426-Sandoz)



Instance: Nurofen-omh-tabl-200-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1427"
* subject = Reference(Nurofen-omh-tabl-200-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1427-Reckitt-Benckiser)



Instance: Nurofen-omh-tabl-Kinderen-200-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1428"
* subject = Reference(Nurofen-omh-tabl-Kinderen-200-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1428-Reckitt-Benckiser)



Instance: Spidifen-oploss-gran-zakjes-200-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "135"
* subject = Reference(Spidifen-oploss-gran-zakjes-200-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-135-Zambon)



Instance: Brufen-siroop-susp-200-mg-5-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1419"
* subject = Reference(Brufen-siroop-susp-200-mg-5-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1419-Mylan-EPD)



Instance: Ibuprofen-EG-siroop-susp-200-mg-5-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1420"
* subject = Reference(Ibuprofen-EG-siroop-susp-200-mg-5-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1420-EG)



Instance: Nurofen-4-siroop-susp-zonder-suiker-Kinderen-200-mg-5-ml-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1421"
* subject = Reference(Nurofen-4-siroop-susp-zonder-suiker-Kinderen-200-mg-5-ml-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1421-Reckitt-Benckiser)



Instance: Nurofen-4-siroop-susp-zonder-suiker-Rood-Kinderen-200-mg-5--RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1422"
* subject = Reference(Nurofen-4-siroop-susp-zonder-suiker-Rood-Kinderen-200-mg-5--MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1422-Reckitt-Benckiser)



Instance: Brufen-filmomh-tabl-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1431"
* subject = Reference(Brufen-filmomh-tabl-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1431-Mylan-EPD)



Instance: Ibuprofen-EG-omh-tabl-deelb-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1432"
* subject = Reference(Ibuprofen-EG-omh-tabl-deelb-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1432-EG)



Instance: Ibuprofen-Sandoz-filmomh-tabl-deelb-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1433"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-deelb-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1433-Sandoz)



Instance: Nurofen-PIP-zachte-caps-Fastcaps-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1429"
* subject = Reference(Nurofen-PIP-zachte-caps-Fastcaps-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1429-PI-Pharma)



Instance: Nurofen-filmomh-tabl-Fasttabs-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1434"
* subject = Reference(Nurofen-filmomh-tabl-Fasttabs-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1434-Reckitt-Benckiser)



Instance: Nurofen-omh-tabl-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1435"
* subject = Reference(Nurofen-omh-tabl-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1435-Reckitt-Benckiser)



Instance: Nurofen-zachte-caps-Fastcaps-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1430"
* subject = Reference(Nurofen-zachte-caps-Fastcaps-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1430-Reckitt-Benckiser)



Instance: Perdofemina-filmomh-tabl-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1436"
* subject = Reference(Perdofemina-filmomh-tabl-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1436-Johnson-Johnson-Consumer)



Instance: Spidifen-filmomh-tabl-deelb-400-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "135"
* subject = Reference(Spidifen-filmomh-tabl-deelb-400-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-135-Zambon)



Instance: Brufen-bruisgran-zakjes-600-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1441"
* subject = Reference(Brufen-bruisgran-zakjes-600-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1441-Mylan-EPD)



Instance: Brufen-filmomh-tabl-Forte-600-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1442"
* subject = Reference(Brufen-filmomh-tabl-Forte-600-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1442-Mylan-EPD)



Instance: Ibuprofen-AB-filmomh-tabl-deelb-600-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1443"
* subject = Reference(Ibuprofen-AB-filmomh-tabl-deelb-600-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1443-Aurobindo)



Instance: Ibuprofen-EG-omh-tabl-deelb-600-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1444"
* subject = Reference(Ibuprofen-EG-omh-tabl-deelb-600-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1444-EG)



Instance: Ibuprofen-Sandoz-filmomh-tabl-deelb-600-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1445"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-deelb-600-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1445-Sandoz)



Instance: Ibuprofen-AB-filmomh-tabl-deelb-800-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1449"
* subject = Reference(Ibuprofen-AB-filmomh-tabl-deelb-800-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1449-Aurobindo)



Instance: Nurofen-Patch-transderm-lok-medic-pleister-200-mg-14-x-10-c-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1424"
* subject = Reference(Nurofen-Patch-transderm-lok-medic-pleister-200-mg-14-x-10-c-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1424-Reckitt-Benckiser)



Instance: Nurofen-zetpil-Kinderen-125-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1418"
* subject = Reference(Nurofen-zetpil-Kinderen-125-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1418-Reckitt-Benckiser)



Instance: Nurofen-zetpil-Kinderen-60-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1446"
* subject = Reference(Nurofen-zetpil-Kinderen-60-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1446-Reckitt-Benckiser)



Instance: Nurofen-200-Fastcaps-200-mg-zachte-caps-2-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1446"
* subject = Reference(Nurofen-200-Fastcaps-200-mg-zachte-caps-2-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1446-Reckitt-Benckiser)



Instance: Ibuprofen-AB-200-mg-filmomh-tabl-24-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1559"
* subject = Reference(Ibuprofen-AB-200-mg-filmomh-tabl-24-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1559-Aurobindo)



Instance: Ibuprofen-AB-400-mg-filmomh-tabl-24-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1559"
* subject = Reference(Ibuprofen-AB-400-mg-filmomh-tabl-24-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1559-Aurobindo)



Instance: Cholemed-filmomh-tabl-deelb-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1558"
* subject = Reference(Cholemed-filmomh-tabl-deelb-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1558-Amophar)



Instance: simvastatine-AB-filmomh-tabl-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1559"
* subject = Reference(simvastatine-AB-filmomh-tabl-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1559-Aurobindo)



Instance: simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1564"
* subject = Reference(simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1564-Impexeco)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1563"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1563-Sandoz)



Instance: simvastine-EG-filmomh-tabl-deelb-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1560"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1560-EG)



Instance: simvastine-Mylan-filmomh-tabl-deelb-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1561"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1561-Mylan)



Instance: simvastine-Teva-filmomh-tabl-deelb-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1562"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1562-Teva)



Instance: Zocor-filmomh-tabl-20-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1565"
* subject = Reference(Zocor-filmomh-tabl-20-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1565-Organon)



Instance: Cholemed-filmomh-tabl-deelb-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1566"
* subject = Reference(Cholemed-filmomh-tabl-deelb-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1566-Amophar)



Instance: simvastatine-AB-filmomh-tabl-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1567"
* subject = Reference(simvastatine-AB-filmomh-tabl-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1567-Aurobindo)



Instance: simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1573"
* subject = Reference(simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1573-Impexeco)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1572"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1572-Sandoz)



Instance: simvastine-EG-PIP-filmomh-tabl-deelb-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1569"
* subject = Reference(simvastine-EG-PIP-filmomh-tabl-deelb-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1569-PI-Pharma)



Instance: simvastine-EG-filmomh-tabl-deelb-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1568"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1568-EG)



Instance: simvastine-Mylan-filmomh-tabl-deelb-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1570"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1570-Mylan)



Instance: simvastine-Teva-filmomh-tabl-deelb-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1571"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1571-Teva)



Instance: Zocor-filmomh-tabl-40-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1574"
* subject = Reference(Zocor-filmomh-tabl-40-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1574-Organon)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-80-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1576"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-80-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1576-Sandoz)



Instance: simvastine-Teva-filmomh-tabl-deelb-80-mg-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1575"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-80-mg-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-1575-Teva)



Instance: NORVALET-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVALET-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INNOVIS-HEALTH-A-E-)



Instance: NORVALET-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVALET-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INNOVIS-HEALTH-A-E-)



Instance: FLODIL-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(FLODIL-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: FLODIL-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(FLODIL-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: AMLODIN-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIN-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: AMLODIN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: AMLIBON-TAB-5MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-TAB-5MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: AMLIBON-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: AMODIPAN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMODIPAN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-SANTA-PHARMA-A-E-)



Instance: AMODIPAN-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMODIPAN-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-SANTA-PHARMA-A-E-)



Instance: PIDOLEN-GENOSEMO-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PIDOLEN-GENOSEMO-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhARMEKs-A-E-)



Instance: PIDOLEN-GENOSEMO-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PIDOLEN-GENOSEMO-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhARMEKs-A-E-)



Instance: AGGOVASK-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AGGOVASK-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PROTON-PHARMA-ANONUME-PhARMAKEUTIKE-ETAIREIA)



Instance: AGGOVASK-CAPS-10MG-CAP-BTx14-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AGGOVASK-CAPS-10MG-CAP-BTx14-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PROTON-PHARMA-ANONUME-PhARMAKEUTIKE-ETAIREIA)



Instance: LODIPIN-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LODIPIN-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IASIS-PHARMA)



Instance: LODIPIN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LODIPIN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IASIS-PHARMA)



Instance: NORMODIN-TAB-5MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMODIN-TAB-5MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENEPHARM-AE)



Instance: NORMODIN-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMODIN-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENEPHARM-AE)



Instance: AMLIBON-BES-TAB-5MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-BES-TAB-5MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: AMLIBON-BES-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-BES-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: BARUDEN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BARUDEN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ANPhARM-ELLAS-A-E-)



Instance: NORDEX-MEDICAL-PHARMAQUALITY-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORDEX-MEDICAL-PHARMAQUALITY-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: AMLORETIN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLORETIN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: AMLORETIN-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLORETIN-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: NORVASC-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVASC-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-UPJOHN-HELLAS-E-P-E-)



Instance: NORVASC-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVASC-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-UPJOHN-HELLAS-E-P-E-)



Instance: ALDOSION-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALDOSION-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ALAPIS-ABEE)



Instance: ALDOSION-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALDOSION-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ALAPIS-ABEE)



Instance: AMLODIPINE-MALEATE-GENERICS-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-MALEATE-GENERICS-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: amlodipine-maleate-GENERICS-TAB-5MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(amlodipine-maleate-GENERICS-TAB-5MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: amlodipine-maleate-GENERICS-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(amlodipine-maleate-GENERICS-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: EVANGIO-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EVANGIO-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: AMLOPRESS-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPRESS-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-FOS-PhARMAKEUTIKE-IKE)



Instance: AMLOPRESS-CAPS-10-MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPRESS-CAPS-10-MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-FOS-PhARMAKEUTIKE-IKE)



Instance: AMLODIL-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIL-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GAP-A-E-)



Instance: NORFAN-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORFAN-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: NORFAN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORFAN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: AXYPLOT-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AXYPLOT-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IAMATICA-MON-EPE)



Instance: AXYPLOT-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AXYPLOT-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IAMATICA-MON-EPE)



Instance: AMLOSILAT-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOSILAT-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ALPHA-GENERICS-THERAPY-AEBEPh)



Instance: AMLOSILAT-CAPS-10-MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOSILAT-CAPS-10-MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ALPHA-GENERICS-THERAPY-AEBEPh)



Instance: DAFOR-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DAFOR-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: DAFOR-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DAFOR-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: VASCODIN-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASCODIN-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-HELP-ABEE)



Instance: VASCODIN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASCODIN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-HELP-ABEE)



Instance: AMLODIPINE-BESILATE-NORMA-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-NORMA-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: AMLODIPINE-BESILATE-NORMA-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-NORMA-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: EVANGIO-CAPS-10MG-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EVANGIO-CAPS-10MG-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: AMLODIPINE-BESILATE-TEVA-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-TEVA-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: AMLODIPINE-BESILATE-TEVA-TAB-5MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-TEVA-TAB-5MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: NOLVAC-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NOLVAC-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhARMATEN-ELLAS-AEBE)



Instance: ABESYL-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ABESYL-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: ABESYL-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ABESYL-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: ANGIORETIC-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANGIORETIC-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: ANGIORETIC-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANGIORETIC-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: PRECARDIN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRECARDIN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-FARMEDIA-AE)



Instance: AMLODIPINE-MYLAN-GENERICS-TAB-5MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-MYLAN-GENERICS-TAB-5MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: AMLODIPINE-MYLAN-GENERICS-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-MYLAN-GENERICS-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: ROVOXID-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ROVOXID-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIAN-A-E-)



Instance: ROVOXID-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ROVOXID-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIAN-A-E-)



Instance: RAMLET-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAMLET-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: RAMLET-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAMLET-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: NORVAGEN-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVAGEN-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-STARGEN-E-P-E-)



Instance: AMILOPID-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMILOPID-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: AMILOPID-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMILOPID-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: AMLOPEN-CAPS-5MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPEN-CAPS-5MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: AMLOPEN-CAPS-10MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPEN-CAPS-10MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: TEGRETOL-TAB-200MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-TAB-200MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: TEGRETOL-SYR-100MG-5ML-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-SYR-100MG-5ML-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: TEGRETOL-CO-R-F-C-T-200MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-CO-R-F-C-T-200MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: TEGRETOL-CO-R-F-C-T-400MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-CO-R-F-C-T-400MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: NUROFEN-FOR-CHILDREN-oral-SUSP-100MG-5ML-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NUROFEN-FOR-CHILDREN-oral-SUSP-100MG-5ML-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-RB-HEALTHCARE-HELLAS-A-E-)



Instance: BRUFEN-F-C-TAB-600MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BRUFEN-F-C-TAB-600MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BGP-PROIONTA-M-E-P-E-)



Instance: BRUFEN-C-TAB-200MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BRUFEN-C-TAB-200MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BGP-PROIONTA-M-E-P-E-)



Instance: BRUFEN-C-TAB-400MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BRUFEN-C-TAB-400MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BGP-PROIONTA-M-E-P-E-)



Instance: ADVIL-C-TAB-200MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ADVIL-C-TAB-200MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PFIZER-ELLAS-A-E-)



Instance: NUROFEN-C-TAB-200MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NUROFEN-C-TAB-200MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-REKIT-MPENKIZER-ELLAS-KhEMIKA-ABEE)



Instance: NUROFEN-SOFT-CAPS-200MG-CAP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NUROFEN-SOFT-CAPS-200MG-CAP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-REKIT-MPENKIZER-ELLAS-KhEMIKA-ABEE)



Instance: ALGOFREN-SYR-100MG-5ML-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-SYR-100MG-5ML-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-SUPP-500MG-SUP-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-SUPP-500MG-SUP-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-F-C-TAB-200MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-F-C-TAB-200MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-F-C-TAB-400MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-F-C-TAB-400MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-F-C-TAB-600MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-F-C-TAB-600MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INTERMED-ABEE)



Instance: PEDEA-SOL-IV-INF-10MG-2ML-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PEDEA-SOL-IV-INF-10MG-2ML-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IPhET-AE)



Instance: NEOPROFEN-SOL-IV-INF-10MG-ML-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NEOPROFEN-SOL-IV-INF-10MG-ML-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IPhET-AE)



Instance: LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: STATINUM-MEDICHROM-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINUM-MEDICHROM-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDICHROM-A-E-)



Instance: STATINUM-MEDICHROM-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINUM-MEDICHROM-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDICHROM-A-E-)



Instance: VERISTIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VERISTIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VIOFAR-EPE)



Instance: STAZOR-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STAZOR-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ADEPhARM-M-E-P-E-)



Instance: STAZOR-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STAZOR-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ADEPhARM-M-E-P-E-)



Instance: GLIPAL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(GLIPAL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IASIS-PHARMA)



Instance: SIMVAPROL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVAPROL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NOVENDIA-PHARMACEUTICALS-EPE)



Instance: SIMVALID-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVALID-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VIVAX-PHARMACEUTICALS-LTD-GREECE)



Instance: LOWCHOLID-F-C-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LOWCHOLID-F-C-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PLUS-PhARMAKEUTIKE-AE)



Instance: SIMVATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIOSPRAY-ABEE)



Instance: SIVINAR-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIVINAR-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ANPhARM-ELLAS-A-E-)



Instance: SIVINAR-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIVINAR-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ANPhARM-ELLAS-A-E-)



Instance: REDUSTEROL-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(REDUSTEROL-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhOINIKsPhARM-EPE)



Instance: REDUSTEROL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(REDUSTEROL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhOINIKsPhARM-EPE)



Instance: LIPEXAL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPEXAL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INNOVIS-PHARMA-A-E-B-E)



Instance: LIPOREX-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOREX-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENEPHARM-AE)



Instance: SIMVACOR-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVACOR-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-KLEBA-APhBEE)



Instance: SIMVACOR-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVACOR-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-KLEBA-APhBEE)



Instance: PRAVOSTIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRAVOSTIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: PRAVOSTIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRAVOSTIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: EXTRASTATIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EXTRASTATIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-S-J-A-PHARM-EPE)



Instance: EXTRASTATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EXTRASTATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-S-J-A-PHARM-EPE)



Instance: SOTOVASTIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SOTOVASTIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BROS-E-P-E-)



Instance: KYMAZOL-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(KYMAZOL-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: KYMAZOL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(KYMAZOL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: NORMOTHERIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMOTHERIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-UNI-PHARMA-KLEON-TSETES-PhARMAKEUTIKA-ERGASTERIA-ABEE)



Instance: NORMOTHERIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMOTHERIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-UNI-PHARMA-KLEON-TSETES-PhARMAKEUTIKA-ERGASTERIA-ABEE)



Instance: LIPOREX-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOREX-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENEPHARM-AE)



Instance: STATINAL-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINAL-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ALET-PHARMACEUTICALS-ABEE)



Instance: STATINAL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINAL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-SPECIFAR-ABEE)



Instance: STASIVA-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STASIVA-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhARMANEL-PhARMAKEUTIKE-A-E-)



Instance: STASIVA-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STASIVA-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIAN-A-E-)



Instance: ZUROCID-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZUROCID-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-STARGEN-E-P-E-)



Instance: ZUROCID-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZUROCID-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-STARGEN-E-P-E-)



Instance: VASTATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASTATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: GOLDASTATIN-F-C-TAB-40MG-TAB-0--RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(GOLDASTATIN-F-C-TAB-40MG-TAB-0--MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PANAGIOTES-LEON-SIA-E-E-)



Instance: GOLDASTATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(GOLDASTATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-LINKER-PHARMACEUTICALS-PANAGIOTES-LEON-SIA-E-E-)



Instance: LEPUR-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LEPUR-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: LEPUR-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LEPUR-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: PRIACIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIACIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: NEZATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NEZATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GRAMMENIDES-AThANASIOS-TOU-DEMETRIOU)



Instance: VERISTIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VERISTIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VIOFAR-EPE)



Instance: SIMVASTATIN-TEVA-F-C-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-TEVA-F-C-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: SIMVASTATIN-TEVA-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-TEVA-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: SIMVASTATIN-TEVA-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-TEVA-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: LIPOPRESS-F-C-TAB-20-MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOPRESS-F-C-TAB-20-MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-HEREMCO-M-E-P-E-)



Instance: LIPOPRESS-F-C-TAB-40-MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOPRESS-F-C-TAB-40-MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-HEREMCO-M-E-P-E-)



Instance: ANTICHOL-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-HELP-ABEE)



Instance: ANTICHOL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-HELP-ABEE)



Instance: RAPTOR-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAPTOR-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDITRINA-EPE)



Instance: RAPTOR-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAPTOR-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDITRINA-EPE)



Instance: MEDISTATIN-RALDEX-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(MEDISTATIN-RALDEX-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDICHROM-A-E-)



Instance: LIPOZID-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOZID-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-INNOVACT-A-E-)



Instance: VELKASTATIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VELKASTATIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BELKA-ELLAS-AEBE)



Instance: VELKASTATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VELKASTATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BELKA-ELLAS-AEBE)



Instance: BEVOSTATIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BEVOSTATIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-DESANT)



Instance: BEVOSTATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BEVOSTATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-DESANT)



Instance: PLACOL-SIMVASTATIN-F-C-TAB-20-MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PLACOL-SIMVASTATIN-F-C-TAB-20-MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: PLACOL-SIMVASTATIN-F-C-TAB-40-MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PLACOL-SIMVASTATIN-F-C-TAB-40-MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: SIMVALARK-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVALARK-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-EDUOSMOS-E-E-ALEBIZOPOULOS-E-E-)



Instance: IAMASTATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(IAMASTATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-IAMATICA-MON-EPE)



Instance: ANTICHOL-F-C-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-HELP-ABEE)



Instance: VERITRAT-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VERITRAT-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhARMEKs-A-E-)



Instance: LUSIMVA-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LUSIMVA-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BALU-AE)



Instance: VASSOR-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASSOR-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: VASSOR-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASSOR-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: STATIVER-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATIVER-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-CROSS-PHARMACEYTICALS-P-C-)



Instance: SIMVASTIL-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTIL-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: SIMVASTIL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTIL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: LOWCHOLID-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LOWCHOLID-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: LOWCHOLID-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LOWCHOLID-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: IPRAMID-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(IPRAMID-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-FARMEDIA-AE)



Instance: IPRAMID-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(IPRAMID-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VENIFAR-LTD-CYPRUS)



Instance: SIMVALID-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVALID-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VIVAX-PHARMACEUTICALS-LTD-GREECE)



Instance: STERYLIP-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STERYLIP-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PHAREL-MONOPROSOPE-IKE)



Instance: SIMVASTATIN-NORMA-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-NORMA-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: SIMVASTATIN-NORMA-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-NORMA-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: DOCTIVERINE-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DOCTIVERINE-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-DOCTUM-PhARMAKEUTIKE-K-GIOKARES-SIA-A-E-)



Instance: DOCTIVERINE-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DOCTIVERINE-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-DOCTUM-PhARMAKEUTIKE-K-GIOKARES-SIA-A-E-)



Instance: PRELON-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRELON-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhARAN-ABEE-PARAGOGES-KAI-EMPORIAS-PhARMAKON)



Instance: PRELON-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRELON-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-ANGELINI-PHARMA-HELLAS-ABEE)



Instance: SIMVASTEROL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTEROL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-LIBYTEC-A-E-)



Instance: ZOCOR-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZOCOR-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: ZOCOR-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZOCOR-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: PRIZELIP-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIZELIP-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PhERAKON-I-K-E-)



Instance: ARSTATIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ARSTATIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-DOC-PHARMA-AE)



Instance: ARSTATIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ARSTATIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-DOC-PHARMA-AE)



Instance: TREMITAL-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TREMITAL-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIORESPOND-E-P-E-)



Instance: RAVOSTAN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAVOSTAN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PLA-PHARMACEUTICALS-A-E-)



Instance: RAVOSTAN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAVOSTAN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PLA-PHARMACEUTICALS-A-E-)



Instance: LIP-DOWN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIP-DOWN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-A-KhATZEANTONOGLOU-VELTIPHARM-EPE)



Instance: LIP-DOWN-F-C-TAB-40-MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIP-DOWN-F-C-TAB-40-MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PHARMAZAC-AE)



Instance: NITASTIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NITASTIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PHARMAZAC-AE)



Instance: NITASTIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NITASTIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PHARMAZAC-AE)



Instance: ZOCOR-F-C-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZOCOR-F-C-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: SIMVASTATIN-GENERICS-F-C-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-GENERICS-F-C-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: SIMVASTATIN-GENERICS-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-GENERICS-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: SIMVASTATIN-GENERICS-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-GENERICS-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: STATOSAN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATOSAN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PHARMAXIA-HELLAS-E-E-)



Instance: PRIACIN-F-C-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIACIN-F-C-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: PRIACIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIACIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: FLUITIN-F-C-TAB-40MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(FLUITIN-F-C-TAB-40MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-PHARMALINK)



Instance: VASTATIN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASTATIN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: SIMVASTATIN-MYLAN-F-C-TAB-10MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-MYLAN-F-C-TAB-10MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MYLAN-S-A-S-SAINT-PRIEST-FRANCE)



Instance: SIMVASTATIN-MYLAN-F-C-TAB-20MG-TAB-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-MYLAN-F-C-TAB-20MG-TAB-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
//TODO: reference organization
* holder = Reference(LOC-MYLAN-S-A-S-SAINT-PRIEST-FRANCE)

